Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ZVRA
ZVRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ZVRA News
Zevra Presents Positive Data on MIPLYFFA for Niemann-Pick Disease at World Symposium
Feb 04 2026
Newsfilter
Zevra Therapeutics Invited to Ring Nasdaq Opening Bell
Feb 02 2026
Newsfilter
Stonepine Capital Fully Exits ANI Pharmaceuticals, Reporting $2.52 Million Loss
Dec 28 2025
Yahoo Finance
Zevra Grants 53,000 Stock Options to Attract New Employees
Dec 12 2025
Newsfilter
Key Stocks Reporting Earnings This Week: Joby, IonQ, AMD, and Others
Nov 03 2025
Benzinga
Zevra Therapeutics (ZVRA): Assessing Valuation After Insider Purchases and Continued Revenue Increase
Oct 10 2025
Yahoo Finance
Zevra Therapeutics Reveals Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)
Oct 06 2025
Newsfilter
Zevra Therapeutics Gains Ground Amid Acquisition Rumors
Sep 25 2025
SeekingAlpha
PepGen Shares Surge 112%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 25 2025
Benzinga
Zevra Therapeutics (ZVRA) Rises 10.4%: Is There More Growth Potential for the Stock?
Sep 25 2025
NASDAQ.COM
Zevra Therapeutics Rises on Acquisition Rumors
Aug 21 2025
SeekingAlpha
Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised)
Aug 15 2025
NASDAQ.COM
Crude Oil Down 1%; Performance Food Group Earnings Top Views
Aug 13 2025
Benzinga
Noteworthy Wednesday Option Activity: AAP, ZVRA, TJX
Aug 13 2025
NASDAQ.COM
Zevra Revenue Jumps 486 Percent in Q2
Aug 13 2025
NASDAQ.COM
After-Hours Earnings Report for August 12, 2025 : CAVA, LITE, HRB, RGTI, INTA, WBTN, GRAL, NVGS, MLYS, STOK, ZVRA, TBPH
Aug 12 2025
NASDAQ.COM
Show More News
